Nutex Health Inc.
NUTX
$176.53
$0.060.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 393.10% | 248.71% | 263.63% | 213.78% | -42.23% |
| Total Depreciation and Amortization | 12.24% | 13.47% | 11.77% | 7.84% | 13.55% |
| Total Amortization of Deferred Charges | 30.25% | 15.82% | -40.64% | -13.80% | -48.62% |
| Total Other Non-Cash Items | 544.53% | 536.44% | 336.48% | 84.52% | 777.06% |
| Change in Net Operating Assets | -16,809.16% | -17,913.83% | -4,729.81% | -6,168.31% | -110.95% |
| Cash from Operations | 733.80% | 415.44% | 2,083.03% | 1,742.77% | 182.85% |
| Capital Expenditure | -223.66% | -14.34% | 72.06% | 75.74% | 55.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 105.36% |
| Divestitures | 100.00% | 149.23% | -- | 65.26% | 65.26% |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -149.64% | 27.03% | 24.70% | 50.12% | 66.76% |
| Total Debt Issued | -47.02% | -12.12% | -46.80% | -61.67% | 11.56% |
| Total Debt Repaid | -15.71% | 9.18% | 41.73% | 22.64% | 0.50% |
| Issuance of Common Stock | -60.96% | -40.38% | -41.72% | 2,198.09% | 1,587.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -12.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1,430.98% | -1,430.98% | -351.72% | 82.09% | 82.09% |
| Other Financing Activities | -890.58% | -431.91% | -23.46% | -23.46% | 27.78% |
| Cash from Financing | -33,951.50% | -595.12% | -2,522.92% | 148.06% | 101.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 493.28% | 594.39% | 2,033.31% | 252.10% | 305.04% |